Cue Health (HLTH) has released an update.
Cue Health Inc. has augmented its board by appointing Rishi Reddy, Tarsadia Investments’ head of Venture and Growth equity investing, as a new director, effective February 16, 2024. As part of an agreement with Tarsadia, Cue Health will expand its board and collaborate on appointing an additional independent director. Tarsadia has agreed to support the board’s nominations and adhere to standstill provisions, limiting their actions as shareholders. Reddy, a seasoned investor with a track record in high-growth tech companies, will also serve on the Nominating and Corporate Governance Committee and participate in the standard director compensation and indemnification policies.
For further insights into HLTH stock, check out TipRanks’ Stock Analysis page.
